CCN3 is a novel endogenous PDGF-regulated inhibitor of glomerular cell proliferation
- 1 January 2008
- journal article
- Published by Elsevier in Kidney International
- Vol. 73 (1), 86-94
- https://doi.org/10.1038/sj.ki.5002584
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- A novel mechanism for BCR-ABL action: stimulated secretion of CCN3 is involved in growth and differentiation regulationBlood, 2006
- Biological responses to PDGF-BB versus PDGF-DD in human mesangial cellsKidney International, 2006
- NOVH increases MMP3 expression and cell migration in glioblastoma cells via a PDGFR‐α‐dependent mechanismThe FASEB Journal, 2003
- Electroporation-mediated PDGF receptor-IgG chimera gene transfer ameliorates experimental glomerulonephritisKidney International, 2001
- Activation of PLC and PI 3 kinase by PDGF receptor α is not sufficient for mitogenesis and migration in mesangial cellsKidney International, 2000
- Novel Approach to Specific Growth Factor Inhibition in VivoThe American Journal of Pathology, 1999
- Pressure Oscillation Regulates Human Mesangial Cell Growth and Collagen SynthesisHypertension, 1998
- Mitogenic effect of platelet-derived growth factor in human glomerular mesangial cells: modulation and/or suppression by inflammatory cytokinesClinical and Experimental Immunology, 1991
- Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation.Journal of Clinical Investigation, 1991
- Monokines and platelet-derived growth factor modulate prostanoid production in growth arrested, human mesangial cellsKidney International, 1990